exercise and glp 1 If You're on a GLP-1, These Exercises Are for You Optimizing GLP-1 therapies for obesity
Description
One recent propensity-matched study even observed a slightly lower lifetime pancreatitis risk in GLP-1RA users (0.3 % vs 0.4 %), possibly reflecting overall better diabetes control [35]

FDA that claimed that Eli Lilly was only able to catch up with demand by the fall of 2024 due to the compounders efforts to supplement supply

Noom reports 70% of microdosing members experience no side effects, potentially improving long-term adherence

Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M)
When the patent lifts, its a free-for-all as rival companies create copycat generic versions
By offering tailored solutions at each stage of the patient journey, manufacturers can create value for a broader range of individuals across the obesity continuum and establish themselves as an end-to-end partner in disease prevention and health management (Figure 2)
